On Sedar, March 8, 2021, Final Shot Orm Propectus, page 13, On Sedar, March 8, 2021, Final Shot Orm Propectus, page 13, Weedmd said: Principal Purposes, Objectives, Milestones------------------------------- One of the Company's primary business objectives is for the Company to become cash flow positive by the end of the 2021 fiscal year. The Company has taken active steps to reach this goal including streaming processes and engaging a third-party consultant to assist with financial planning and adopting certain efficiencies. The Company believes that in order to meet this objective it must increase revenues from sales of the Company's products during the 2021 fiscal year. In order to increase sales, the Company plans to allocate funds to increased marketing and sales efforts, the expansion of product lines and operational capacity and output. While the Company had initially contemplated such amounts being expended over the next 12 to 18 months, with the net proceeds from the Offering, the timing of such initiatives can be accelerated such that the Company expects to see results of such initiatives during the 2021 fiscal year . The specific amounts to be allocated to each of these activities has been estimated as follows:------------------------------------------- Milestones Sales and Marketing Initiatives for Q2-Q4 2021:$ 7,098,000 --------- Increased Operational Capacity :$ 4,352,000 ------------------ Product Development $ 2,250,000 ----------------- (1) (4) Total : $ 13,700,000